When AI Shapes the Narrative: Do Pubs Teams Have a Responsibility to Act?

Your team at a sponsoring pharmaceutical company recently published a clinical study in a reputable journal. Soon after, a healthcare professional shared a summary generated by an AI-powered medical tool that appears to overstate the study’s efficacy and underrepresent key limitations. The AI summary is gaining traction in online discussions. While the original published abstract is accurate, you recognize that its structure may make it easier for AI tools to generate simplified, and potentially misleading, interpretations. Now, there is internal debate about whether your team has any responsibility to respond. Some colleagues argue that once the manuscript is published, interpretation by third-party tools is out of the authors’ or the company’s control. Others believe there is a professional obligation to step in when summaries derived from a company-sponsored publication could influence clinical understanding. As a publications lead, you are asked how to proceed. What Would You Do?